David Feitel serves as Executive at MARTEK BIOSCIENCES CORP, where they oversee executive responsibilities. Since joining the company, David Feitel has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 25, 2011 involved receiving (via award) 31,881 shares valued at $0.
David Feitel currently holds 31,881 shares of MARTEK BIOSCIENCES CORP (MATK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Feitel has been a net neutral trader of MATK stock. They have purchased $0 and sold $0 worth of shares.
David Feitel's most recent insider trade was on Feb 25, 2011, when they sold 31,881 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $31.50 |
| Discretionary |
| Feb 18, 2011 | MATK | $40.7K | Tender | 1,292.77 | $31.50 | Discretionary |
| Feb 18, 2011 | MATK | $179.1K | Tender | 5,687 | $31.50 | Discretionary |
| Mar 19, 2010 | MATK | $0 | Option Exercise | 4,698 | $N/A | Discretionary |
| Mar 19, 2010 | MATK | $36.8K | Payment | 1,540 | $23.88 | Discretionary |
| Mar 19, 2009 | MATK | $0 | Option Exercise | 2,520 | $N/A | Discretionary |
| Mar 19, 2009 | MATK | $15.3K | Payment | 898 | $17.07 | Discretionary |
| Mar 19, 2008 | MATK | $15.5K | Payment | 511 | $30.39 | Discretionary |
| Mar 19, 2008 | MATK | $0 | Option Exercise | 1,418 | $N/A | Discretionary |